Document is current
Any future updates will be listed below
-
Authors
Bousard, Aurélie
Raposo, Ana Cláudia
Żylicz, Jan Jakub
Picard, Christel
Pires, Vanessa Borges
Qi, Yanyan
Gil, Cláudia
Syx, Laurène
Chang, Howard Y
Heard, Edith https://orcid.org/0000-0001-8052-7117
da Rocha, Simão Teixeira https://orcid.org/0000-0002-9683-7942
-
Funding
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (PTDC/BEX‐BCM/2612/2014)
Fundação para a Ciência e a Tecnologia (PTDC/BIA‐MOL/29320/2017)
Fundação para a Ciência e a Tecnologia (IF/00242/2014)
Fundação para a Ciência e a Tecnologia (UID/BIM/50005/2019)
H2020 European Research Council (ERC‐ADG‐2014 671027)
Scleroderma Research Foundation
National Institute for Health Research (NIH P50‐HG007735)
- License Information
-
More Information
Article History
Received: 28 February 2019
Revised: 29 July 2019
Accepted: 6 August 2019
First Online: 27 August 2019
Conflict of interest
: H.Y.C. is a co‐founder of Accent Therapeutics, Boundless Bio, and advisor to 10X Genomics, Arsenal Biosciences, and Spring Discovery. The other authors declare that they have no conflict of interest.
